Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Pharma Com (India)

Sector: Healthcare | Industry: Drugs & Pharma
R 7.04 0.00  | 0.00% -63.90% 50.33 22.60
BSE Price: Sep 30, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Sep 30, 2019 7.04 0.00 0.00% 7.04 7.04 200 7.04 - 7.04
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 22,901 P/B: 5.62 NSE Code:
52-Week Range: R 7.04 - 18.55 Dividend Yield: 0.00% BSE Code: 516110
TTM EPS: R 0.14 Book Value: R 1.25 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 173.48 136.68 302.69
Net Profit -97.77 -1.83 15.52
EPS -97.77 -1.91 14.93
Book Value 0.49 8.12 27.03
Average
Operating Margin 10.60 22.22 2.66
Net Margin 0.13 7.95 -2,757.79
Return on Networth 0.38 7.76 -274.20
Return on Investment 10.74 13.67 -211.00
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -55.99 23.63 -55.99
Operating Profit -128.16 54.00 -128.16
Net Profit -172.89 30.80 -172.89
EPS -172.89 30.80 -172.89
TTM
Revenue 3.05 143.32 3.05
Operating Profit 38.69 1,847.06 38.69
Net Profit 1,852.17 143.68 1,852.17
EPS 1,843.06 143.68 1,843.06
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Pharma Com (India) 22.60 14.62 0.45 3.02 0.38 5.62 50.33
Astrazeneca Pharma India 6,332.38 771.42 69.56 8.84 20.03 19.78 91.03
Eris Lifesciences 5,764.14 1,005.70 303.64 29.29 28.96 4.67 18.99
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Dec 18, 2014 Gautam Deshpande  Buy Preferential Allotment 15,000,000 - -
Dec 16, 2014 Sareen Enterprises  Buy Preferential Allotment 4,000,000 - -
Dec 16, 2014 Shree Balaji Enterprises  Buy Preferential Allotment 7,700,000 - -
Jul 05, 2014 Reveal Developers Pvt. Ltd.  Buy Off Market 142,600 - -
News & Announcements
Contact Information

Company: Pharma Com (India) Ltd.

Address: Plot No. A-357, Road No. 26, Wagle Industrial Estate, M I D C, Thane (West), Thane, Maharashtra - 400604 | Phone: 022 25833205 | Fax: 022 41842228

Email: [email protected]

Website: www.scandent.in

Registrar & Transfer Agent: Purva Shareregistry (India) Pvt Ltd

Address: Gala No 9, Shiv Shakti, Industrial EstateSitaram Mill Compound, J R Boricha Marg, Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E]

Essential checks
Altman Z-Score
-0.35
Piotroski F-Score
6
Modified C-Score
2
3-Years Price to Earnings
50.33
3-Years Price to Book
5.62
Earnings Yield
EBIT / Enterprise value
4.74%
PEG
Price / Earnings to growth ratio
0.25
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,531.95 +4.97%
Caplin Point Laboratories R382.95 -1.24%
Eris Lifesciences R421.25 -0.98%
FDC R159.30 -1.03%
JB Chemicals & Pharma R355.00 -1.33%
Laurus Labs R348.00 +1.84%
Strides Pharma Science R343.50 -2.07%
Sun Pharma Adv. Research R129.30 -2.49%
Suven Life Sciences R288.40 +0.61%
Wockhardt R269.80 -1.96%
As on Oct 23, 15:59